Followers | 9840 |
Posts | 260002 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Thursday, November 14, 2019 5:25:23 PM
Link to Video - click here to watch the technical chart video
Recent HROW News
- Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024 • Business Wire • 04/25/2024 11:00:00 AM
- Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing • Business Wire • 04/02/2024 12:16:00 PM
- JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News • IH Market News • 03/20/2024 11:15:48 AM
- Harrow Announces Fourth Quarter and Year-End 2023 Financial Results • Business Wire • 03/19/2024 09:45:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:06:28 AM
- Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024 • Business Wire • 03/05/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:30:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:29:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:15:33 PM
- Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products • Business Wire • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:30:18 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/29/2024 08:26:29 PM
- Harrow Announces New Appointments to its Board of Directors • Business Wire • 01/29/2024 12:00:00 PM
- Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease • Business Wire • 01/11/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/09/2024 03:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:00:37 PM
- Melt Pharmaceuticals Provides Corporate Update • Business Wire • 01/03/2024 12:15:00 PM
- Harrow Partners with Leading Healthcare Market Access Technology Platforms • Business Wire • 01/03/2024 12:00:00 PM
- Harrow Completes Transfer of the TRIESENCE® New Drug Application • Business Wire • 11/29/2023 12:00:00 PM
- Harrow to Present at Two Investor Conferences in November • Business Wire • 11/20/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 09:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 12:02:22 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM